 | Up a level |
Cuthbertson, Daniel J 
ORCID: 0000-0002-6128-0822, Shojaee-Moradie, Fariba, Sprung, Victoria S ORCID: 0000-0002-2666-4986, Jones, Helen, Pugh, Christopher JA, Richardson, Paul, Kemp, Graham J ORCID: 0000-0002-8324-9666, Barrett, Mark, Jackson, Nicola C, Thomas, E Louise et al (show 2 more authors)
(2016)
Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease.
CLINICAL SCIENCE, 130 (2).
pp. 93-104.
Whyte, Martin B, Shojaee-Moradie, Fariba, Sharaf, Sharaf E, Cuthbertson, Daniel J ORCID: 0000-0002-6128-0822, Kemp, Graham J ORCID: 0000-0002-8324-9666, Barrett, Mark, Jackson, Nicola C, Herring, Roselle A, Wright, John, Thomas, E Louise et al (show 2 more authors)
(2020)
HDL-apoA-I kinetics in response to 16 wk of exercise training in men with nonalcoholic fatty liver disease.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 318 (6).
E839-E847.
Brown, Emily, Wilton, Moon M ORCID: 0000-0003-4052-7918, Sprung, Victoria S ORCID: 0000-0002-2666-4986, Harrold, Joanne A ORCID: 0000-0002-0899-4586, Halford, Jason CG ORCID: 0000-0003-1629-3189, Stancak, Andrej ORCID: 0000-0003-3323-3305, Burgess, Malcolm, Howarth, Elaine, Umpleby, A Margot, Kemp, Graham J ORCID: 0000-0002-8324-9666 et al (show 2 more authors)
(2021)
A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol.
BMJ open, 11 (7).
e045663-e045663.